Loading clinical trials...
Loading clinical trials...
Phase II Study of Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma
Conditions
Interventions
Regorafenib
Locations
7
United States
Memorial Sloan Kettering Cancer Center at Basking Ridge
Basking Ridge, New Jersey, United States
Downstate Medical Center
Brooklyn, New York, United States
Memorial Sloan Kettering Cancer Center at Commack
Commack, New York, United States
Queens Cancer Center of Queens Hospital
Jamaica, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
Rockville Centre, New York, United States
Start Date
December 10, 2013
Primary Completion Date
August 26, 2025
Completion Date
August 26, 2025
Last Updated
August 27, 2025
NCT02600949
NCT06696768
NCT04511039
NCT07130903
NCT05312398
NCT05356897
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions